Zimmer (NYSE:ZMH) president & CEO David Dvorak is looking to avoid layoffs as much as possible following the pending mega-merger with long-time rival Biomet.
Zimmer Biomet
Teleflex announces plans to cut costs and streamline manufacturing | Medtech Wall Street news for the week of May 5, 2014
Morgan Stanley: Medtech underperformed in April
The medical device sector under-performed the S&P 500 index in April after a sharp swing over-performance during the 1st quarter, according to analysts at Morgan Stanley.
The 30 medtech stocks Morgan Stanley covers collectively under-performed the S&P by 4.1%, after besting the index by 4.9% during the 1st quarter.
Medtech trends: The most talked about device makers in April 2014
C.R. Bard posted major profit growth in its 1st quarter | Medtech Wall Street news for the week of Apr. 28, 2014
The new face of ortho: Zimmer to take 2nd place with $13.4B Biomet buy
Zimmer beats The Street, alters 2014 forecast on Biomet buy
Ortho shakeup: Zimmer to acquire Biomet in deal worth $13.35 billion
Zimmer brings new ‘no profile’ Optio-C spine implant to the U.S.
Google Glass startup gains funding for flagship product | Medtech funding stories for the week of Mar. 17, 2014
Zimmer, Draeger and Altitude tally $234M in Pentagon supply deals
A trio of medical device makers collected Pentagon supply deals worth a collective $234.3 million, according to recent Defense Dept. reports.